{"name": "Clearside Biomedical",
 "permalink": "clearside-biomedical",
 "crunchbase_url": "http://www.crunchbase.com/company/clearside-biomedical",
 "homepage_url": "http://www.clearsidebio.com/",
 "blog_url": "",
 "blog_feed_url": "http://clearsidebio.com/news/press-releases/",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2011,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Jan 05 13:03:33 UTC 2012",
 "updated_at": "Tue Apr 09 03:31:12 UTC 2013",
 "overview": "\u003Cp\u003EClearside BioMedical, Inc., an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as retina, trabecular meshwork, and corneal stroma. The company\u2019s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "",
    "person":
     {"first_name": "Benjamin",
      "last_name": "Yerxa",
      "permalink": "benjamin-yerxa",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$4M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.newsobserver.com/2012/01/05/1753645/clearside-raises-4-million-to.html",
    "source_description": "Clearside raises $4 million to advance its eye treatment",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 1,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Hatteras Venture Partners",
         "permalink": "hatteras-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/6917/46917v2-max-150x150.png"],
             [[250,
               65],
              "assets/images/resized/0004/6917/46917v2-max-250x250.png"],
             [[393,
               103],
              "assets/images/resized/0004/6917/46917v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": " 1220 Old Alpharetta Rd.",
    "address2": ", Suite 300",
    "zip_code": "GA 30005",
    "city": " Alpharetta, ",
    "state_code": null,
    "country_code": "USA",
    "latitude": 34.103755,
    "longitude": -84.206528},
   {"description": "North Carolina ",
    "address1": "510 Glenwood Ave., ",
    "address2": "Suite 317",
    "zip_code": "NC 27603",
    "city": " Raleigh, ",
    "state_code": null,
    "country_code": "USA",
    "latitude": 35.786975,
    "longitude": -78.647003}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}